Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

POLIRNA

Financiado

Kits for advanced polymer-lipid nanocarriers for targeted delivery of RNAs to ca...

Kits for advanced polymer-lipid nanocarriers for targeted delivery of RNAs to cardiac and skeletal muscle cells Currently, RNA therapies are available on the clinics to treat liver diseases and as COVID-19 vaccines. Hence, their therapeutic potential still remains largely unexploited for the treatment of other disorders, such as age-related... ver más

31/03/2025

POLITO

150K€

Presupuesto del proyecto: 150K€

Líder del proyecto

POLITECNICO DI TORINO No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-03-20

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

ERC-2022-POC2: ERC PROOF OF CONCEPT GRANTS2

I+D

Cerrada hace 2 años

0% 100% 100%

1 Participantes

POLITO

150.00K€ | Lider

Proyectos interesantes

PID2021-127493OB-C21 HERRAMIENTAS TECNOLOGICAS PARA EL CONTROL DEL TRAFICO SISTEM... 183K€ Cerrado

PID2020-114356RB-I00 VECTORES NO VIRALES PARA TERAPIA GENICA BASADOS EN NANOPARTI... 213K€ Cerrado

BIO2013-41019-P INGENIERIA DE NANOPARTICULAS PROTEICAS PARA LA ENTREGA DIRIG... 151K€ Cerrado

RTI2018-095214-B-I00 ESTUDIO IN VIVO DE TERAPIAS MOLECULARES DE DISEÑO Y UN NANO-... 121K€ Cerrado

TraffikGene-Tx TraffikGene-Tx: Targeted Peptide Carriers for RNA Delivery 2M€ Cerrado

CTQ2010-18195 NANOFARMACOS POLIMERICOS UTILIZADOS COMO AGENTES SIMPLES Y E... 120K€ Cerrado

Últimas noticias

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

29-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 37 concesiones

Duración del proyecto: 24 meses Fecha Inicio: 2023-03-20
Fecha Fin: 2025-03-31

Líder del proyecto

POLITECNICO DI TORINO

TRL 4-5

Presupuesto del proyecto 150K€

Descripción del proyecto Currently, RNA therapies are available on the clinics to treat liver diseases and as COVID-19 vaccines. Hence, their therapeutic potential still remains largely unexploited for the treatment of other disorders, such as age-related, rare genetic and infectious diseases. One key problem for effective preclinical research on new RNA therapies is the lack of safe, efficient and cell-specific delivery vehicles. Gold-standard cationic lipid transfection reagents suffer from dose-dependent cytotoxicity, inability for cell-targeted delivery and poor stability. Clinically approved lipid nanoparticles efficiently target liver cells, while attempts to target other cell types have achieved limited success. In POLIRNA I will develop and validate a new safe, efficient, and versatile platform for RNA release to target multiple cell types, based on ligand-functionalized polymer-lipid nanocarriers, by exploiting a new patented method from my ERC-funded project BIORECAR (772168). POLIRNA consists of kits for research use, allowing user-friendly preparation of nanocarriers able to effectively deliver non-coding RNAs (such as siRNAs and microRNAs) to target cardiomyocytes and skeletal muscle cells for preclinical research studies on cardiac regenerative medicine and muscle-related diseases (e.g., neuromuscular diseases). Technology development and validation will benefit from collaboration with major experts in the fields and companies supporting the innovation route from lab-to-market. My previous experience as coordinator of research and innovation projects and as co-founding member of an academic spin-off company, and the current involvement of my team in business plan competitions will drive the process of technology validation, with the aim to strengthen technology value proposition versus current gold-standard solutions, found a start-up company and attract investments.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores